Regenerative Medical Technology Group Furnishes Aug 20, 2026 Investor Call Transcript

What Happened

• Regenerative Medical Technology Group Inc. filed a Form 8-K on August 25, 2026, furnishing (under Item 7.01/8.01) the transcript of an investor video call held on August 20, 2026.
• Management provided prepared remarks and answered questions that shareholders submitted in advance; the transcript is included as Exhibit 99.1 to the 8-K.
• The company notes the transcript is furnished under Regulation FD and is not “filed” for purposes of Section 18 of the Exchange Act, nor is it incorporated by reference into other filings except where explicitly stated.

Key Details

• Date of investor call: August 20, 2026.
• Form 8-K filed: August 25, 2026 (Items 7.01 and 8.01); transcript furnished as Exhibit 99.1.
• Transcript furnished (not “filed”) under Regulation FD — limited liability under Section 18.
• Management addressed pre-submitted shareholder questions and provided prepared remarks; no new financial results or executive changes were reported in this filing.

Why It Matters

• The transcript gives investors direct access to management’s public statements and answers to shareholder questions, which can clarify strategy, milestones, or operational status without waiting for formal filings.
• Because the transcript is furnished under Regulation FD and not “filed,” it carries different legal implications (limited Section 18 liability) than material statements included in filed disclosures.
• Investors who want up-to-date commentary from company leadership should read the Exhibit 99.1 transcript to assess tone, near-term plans, or any operational details discussed during the call.